Zahar JR - Search Results

1

Management of multidrug resistant bacterial endemic.

Zahar JR, Lesprit P. Zahar JR, et al. Med Mal Infect. 2014 Sep;44(9):405-11. doi: 10.1016/j.medmal.2014.07.006. Epub 2014 Aug 29. Med Mal Infect. 2014. PMID: 25169940 Review.

2

Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?

Pilmis B, Delory T, Groh M, Weiss E, Emirian A, Lecuyer H, Lesprit P, Zahar JR. Pilmis B, et al. Among authors: zahar jr. Int J Infect Dis. 2015 Oct;39:62-7. doi: 10.1016/j.ijid.2015.08.011. Epub 2015 Sep 12. Int J Infect Dis. 2015. PMID: 26327124 Free article.

3

Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints.

Farfour E, Degand N, Riverain E, Fihman V, Le Brun C, Péan de Ponfilly G, Muggeo A, Jousset A, Piau C, Lesprit P; GMC study group. Farfour E, et al. Med Mal Infect. 2020 Oct;50(7):611-616. doi: 10.1016/j.medmal.2020.07.003. Epub 2020 Jul 15. Med Mal Infect. 2020. PMID: 32679342

4

Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.

Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, Lucet JC, Paugam-Burtz C, Brun-Buisson C, Timsit JF; De-escalation Study Group. Weiss E, et al. Among authors: zahar jr. Clin Microbiol Infect. 2015 Jul;21(7):649.e1-10. doi: 10.1016/j.cmi.2015.03.013. Epub 2015 Apr 13. Clin Microbiol Infect. 2015. PMID: 25882363 Free article.

5

Severe soft tissue infections of the extremities in patients admitted to an intensive care unit.

Zahar JR, Goveia J, Lesprit P, Brun-Buisson C. Zahar JR, et al. Clin Microbiol Infect. 2005 Jan;11(1):79-82. doi: 10.1111/j.1469-0691.2004.01027.x. Clin Microbiol Infect. 2005. PMID: 15649312 Free article.

6

Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use.

Lepeule R, Leflon-Guibout V, Vanjak D, Zahar JR, Lafaurie M, Besson C, Lefort A; Groupe des Référents en Infectiologie d’Île-de-France (GRIF). Lepeule R, et al. Among authors: zahar jr. Med Mal Infect. 2014 Dec;44(11-12):530-4. doi: 10.1016/j.medmal.2014.09.004. Epub 2014 Oct 11. Med Mal Infect. 2014. PMID: 25311839

7

Antimicrobial resistance in community-acquired urinary tract infections in Paris in 2015.

Chervet D, Lortholary O, Zahar JR, Dufougeray A, Pilmis B, Partouche H. Chervet D, et al. Among authors: zahar jr. Med Mal Infect. 2018 May;48(3):188-192. doi: 10.1016/j.medmal.2017.09.013. Epub 2017 Oct 18. Med Mal Infect. 2018. PMID: 29054298

8

[Epidemiology of patients harboring extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE), on admission].

Guillet M, Bille E, Lecuyer H, Taieb F, Masse V, Lanternier F, Lage-Ryke N, Talbi A, Degand N, Lortholary O, Nassif X, Zahar JR. Guillet M, et al. Among authors: zahar jr. Med Mal Infect. 2010 Nov;40(11):632-6. doi: 10.1016/j.medmal.2010.04.006. Med Mal Infect. 2010. PMID: 20554140 French.

9

[Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues].

Lepelletier D, Batard E, Berthelot P, Zahar JR, Lucet JC, Fournier S, Jarlier V, Grandbastien B. Lepelletier D, et al. Among authors: zahar jr. Rev Med Interne. 2015 Jul;36(7):474-9. doi: 10.1016/j.revmed.2014.12.006. Epub 2015 Jan 15. Rev Med Interne. 2015. PMID: 25600328 Review. French.

10

Update on Clostridium difficile infections.

Le Monnier A, Zahar JR, Barbut F. Le Monnier A, et al. Among authors: zahar jr. Med Mal Infect. 2014 Aug;44(8):354-65. doi: 10.1016/j.medmal.2014.04.002. Epub 2014 Aug 22. Med Mal Infect. 2014. PMID: 25156678 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters